Onyx Biotec Limited, a prominent player in the biotechnology sector, is headquartered in India and operates extensively across various regions. Founded in 2010, the company has established itself as a leader in developing innovative biopharmaceuticals and advanced therapeutic solutions. Specialising in cutting-edge drug delivery systems and bioprocessing technologies, Onyx Biotec's core offerings are distinguished by their commitment to enhancing patient outcomes and streamlining production processes. The company has achieved significant milestones, including collaborations with leading research institutions and successful product launches that underscore its market position. With a focus on quality and innovation, Onyx Biotec Limited continues to drive advancements in the biotechnology industry, making a notable impact on healthcare solutions both locally and globally.
How does Onyx Biotec Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Onyx Biotec Limited's score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Onyx Biotec Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Onyx Biotec Limited may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their carbon footprints. However, without specific commitments or data, it is challenging to assess Onyx Biotec Limited's position relative to its peers in terms of climate action and emissions management.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Onyx Biotec Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

